Hari Chandana Mulamalla

Title: Innovations in Cancer Therapy by Hari Chandana Mulamalla

Introduction

Hari Chandana Mulamalla is an innovative inventor based in Monroe Township, NJ (US). He has made significant contributions to the field of cancer therapy through his research and inventions. His work focuses on developing targeted delivery systems for therapeutic agents, which can enhance the effectiveness of treatments for hyperproliferative diseases.

Latest Patents

Hari Chandana Mulamalla holds a patent for "Targeted liposomes in cancer therapy." This invention provides pharmaceutical compositions that contain a vehicle designed for the targeted delivery of therapeutic and diagnostic agents. The targeting component of the vehicle is a cystine molecule that is coupled to the cargo component, which can either be a therapeutic or diagnostic agent or a nanoparticle composition containing the therapeutic agent or diagnostic. The invention also outlines methods for treating hyperproliferative disorders by specifically targeting hyperproliferative disease cells for the delivery of therapeutic or diagnostic agents. He has 1 patent to his name.

Career Highlights

Hari Chandana Mulamalla is affiliated with the Western University of Health Sciences, where he continues to advance his research in pharmaceutical sciences. His work is pivotal in developing innovative solutions for cancer treatment, showcasing his commitment to improving patient outcomes.

Collaborations

Hari collaborates with esteemed colleagues, including Maria Polikandritou Lambros and Ying Huang. Their combined expertise contributes to the advancement of research in targeted therapies.

Conclusion

Hari Chandana Mulamalla's innovative work in cancer therapy exemplifies the potential of targeted delivery systems in improving treatment efficacy. His contributions are vital in the ongoing fight against hyperproliferative diseases.